|
1
|
Pancreatic Cancer. Cancer Research UK, .
https://www.cancerresearchuk.org/about-cancer/pancreatic-cancerMarch
21–2019
|
|
2
|
Klaiber U, Leonhardt CS, Strobel O, Tjaden
C, Hackert T and Neoptolemos JP: Neoadjuvant and adjuvant
chemotherapy in pancreatic cancer. Langenbecks Arch Surg.
403:917–932. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ling S, Feng T, Jia K, Tian Y and Li Y:
Inflammation to cancer: The molecular biology in the pancreas
(Review). Oncol Lett. 7:1747–1754. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frampas E, David A, Regenet N, Touchefeu
Y, Meyer J and Merla O: Pancreatic carcinoma: Key-points from
diagnosis to treatment. Diagn Interv Imaging. 97:1207–1223. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hirabayashi T, Nakamachi T and Shioda S:
Discovery of PACAP and its receptors in the brain. J Headache Pain.
19:282018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miyata A, Arimura A, Dahl RR, Minamino N,
Uehara A, Jiang L, Culler MD and Coy DH: Isolation of a novel 38
residue-hypothalamic polypeptide which stimulates adenylate cyclase
in pituitary cells. Biochem Biophys Res Commun. 164:567–574. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miyata A, Jiang L, Dahl RD, Kitada C, Kubo
K, Fujino M, Minamino N and Arimura A: Isolation of a neuropeptide
corresponding to the N-terminal 27 residues of the pituitary
adenylate cyclase activating polypeptide with 38 residues
(PACAP38). Biochem Biophys Res Commun. 170:643–648. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ojala J, Tooke K, Hsiang H, Girard BM, May
V and Vizzard MA: PACAP/PAC1 expression and function in micturition
pathways. J Mol Neurosci. 68:357–367. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reglodi D, Illes A, Opper B, Schafer E,
Tamas A and Horvath G: Presence and effects of pituitary adenylate
cyclase activating polypeptide under physiological and pathological
conditions in the stomach. Front Endocrinol (Lausanne). 9:902018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lajko A, Meggyes M, Fulop BD, Gede N,
Reglodi D and Szereday L: Comparative analysis of decidual and
peripheral immune cells and immune-checkpoint molecules during
pregnancy in wild-type and PACAP-deficient mice. Am J Reprod
Immunol. 80:e130352018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Parsons RL and May V: PACAP-induced PAC1
receptor internalization and recruitment of endosomal signaling
regulate cardiac neuron excitability. J Mol Neurosci. 68:340–347.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sarszegi Z, Szabo D, Gaszner B, Konyi A,
Reglodi D, Nemeth J, Lelesz B, Polgar B, Jungling A and Tamas A:
Examination of pituitary adenylate cyclase-activating polypeptide
(PACAP) as a potential biomarker in heart failure patients. J Mol
Neurosci. 68:368–376. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reglodi D and Tamas A: Pituitary Adenylate
Cyclase Activating Polypeptide-PACAPCurr Topics Neurotox Springer
Int. Switzerland: pp. 1–840. 2016
|
|
14
|
Vaudry D, Falluel-Morel A, Bourgault S,
Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H,
Galas L and Vaudry H: Pituitary adenylate cyclase-activating
polypeptide and its receptors: 20 years after the discovery.
Pharmacol Rev. 61:283–357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Elsås T, Uddman R and Sundler F: Pituitary
adenylate cyclase-activating peptide-immunoreactive nerve fibers in
the cat eye. Graefes Arch Clin Exp Ophthalmol. 234:573–580. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gaal V, Mark L, Kiss P, Kustos I, Tamas A,
Kocsis B, Lubics A, Nemeth V, Nemeth A, Lujber L, et al:
Investigation of the effects of PACAP on the composition of tear
and endolymph proteins. J Mol Neurosci. 36:321–329. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakamachi T, Ohtaki H, Seki T, Yofu S,
Kagami N, Hashimoto H, Shintani N, Baba A, Mark L, Lanekoff I, et
al: PACAP suppresses dry eye signs by stimulating tear secretion.
Nat Commun. 7:120342016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pedersen AM, Dissing S, Fahrenkrug J,
Hannibal J, Reibel J and Nauntofte B: Innervation pattern and Ca2+
signalling in labial salivary glands of healthy individuals and
patients with primary Sjögren's syndrome (pSS). J Oral Pathol Med.
29:97–109. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Skakkebaek M, Hannibal J and Fahrenkrug J:
Pituitary adenylate cyclase activating polypeptide (PACAP) in the
rat mammary gland. Cell Tissue Res. 298:153–159. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tobin G, Asztély A, Edwards AV, Ekström J,
Håkanson R and Sundler F: Presence and effects of pituitary
adenylate cyclase activating peptide in the submandibular gland of
the ferret. Neuroscience. 66:227–235. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matoba Y, Nonaka N, Takagi Y, Imamura E,
Narukawa M, Nakamachi T, Shioda S, Banks WA and Nakamura M:
Pituitary adenylate cyclase-activating polypeptide enhances saliva
secretion via direct binding to PACAP receptors of major salivary
glands in mice. Anat Rec (Hoboken). 299:1293–1299. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calvert PA, Heck PM and Edwards AV:
Autonomic control of submandibular protein secretion in the
anaesthetized calf. Exp Physiol. 83:545–556. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kamaishi H, Endoh T and Suzuki T: Multiple
signal pathways coupling VIP and PACAP receptors to calcium
channels in hamster submandibular ganglion neurons. Auton Neurosci.
111:15–26. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mirfendereski S, Tobin G, Håkanson R and
Ekström J: Pituitary adenylate cyclase activating peptide (PACAP)
in salivary glands of the rat: Origin, and secretory and vascular
effects. Acta Physiol Scand. 160:15–22. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schmidt WE, Seebeck J, Höcker M,
Schwarzhoff R, Schäfer H, Fornefeld H, Morys-Wortmann C, Fölsch UR
and Creutzfeldt W: PACAP and VIP stimulate enzyme secretion in rat
pancreatic acini via interaction with VIP/PACAP-2 receptors:
Additive augmentation of CCK/carbachol-induced enzyme release.
Pancreas. 8:476–487. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sakurai Y, Shintani N, Hayata A, Hashimoto
H and Baba A: Trophic effects of PACAP on pancreatic islets: A
mini-review. J Mol Neurosci. 43:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hamagami K, Sakurai Y, Shintani N, Higuchi
N, Ikeda K, Hashimoto H, Suzuki A, Kiyama H and Baba A:
Over-expression of pancreatic pituitary adenylate
cyclase-activating polypeptide (PACAP) aggravates cerulein-induced
acute pancreatitis in mice. J Pharmacol Sci. 110:451–458. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jung S, Yi L, Jeong D, Kim J, An S, Oh TJ,
Kim CH, Kim CJ, Yang Y, Kim KI, Lim JS and Lee MS: The role of
ADCYAP1, adenylate cyclase activating polypeptide, as a methylation
biomarker for the early detection of cervical cancer. Oncol Rep.
25:245–252. 2011.PubMed/NCBI
|
|
29
|
Moody TW, Chan D, Fahrenkrug J and Jensen
RT: Neuropeptides as autocrine growth factors in cancer cells. Curr
Pharm Des. 9:495–509. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moody TW, Nuche-Berenguer B and Jensen RT:
Vasoactive intestinal peptide/pituitary adenylate cyclase
activating polypeptide, and their receptors and cancer. Curr Opin
Endocrinol Diabetes Obes. 23:38–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moody TW and Jensen RT: PACAP and
cancerPituitary Adenylate Cyclase Activating Polypeptide-PACAP.
Reglodi D and Tamas A: Springer Int.; Switzerland: pp. 795–814.
2016, View Article : Google Scholar
|
|
32
|
Schulz S, Röcken C, Mawrin C, Weise W,
Höllt V and Schulz S: Immunocytochemical identification of VPAC1,
VPAC2, and PAC1 receptors in normal and neoplastic human tissues
with subtype-specific antibodies. Clin Cancer Res. 10:8235–8242.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schulz S, Mann A, Novakhov B, Piggins HD
and Lupp A: VPAC2 receptor expression in human normal and
neoplastic tissues: Evaluation of the novel MAB SP235. Endocr
Connect. 4:18–26. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wojcieszak J and Zawilska JB: PACAP38 and
PACAP6-38 exert cytotoxic activity against human retinoblastoma Y79
cells. J Mol Neurosci. 54:463–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schäfer H, Lettau P, Trauzold A, Banasch M
and Schmidt WE: Human PACAP response gene 1 (p22/PRG1):
Proliferation-associated expression in pancreatic carcinoma cells.
Pancreas. 18:378–384. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schäfer H, Zheng J, Gundlach F, Günther R
and Schmidt WE: PACAP stimulates transcription of c-Fos and c-Jun
and activates the AP-1 transcription factor in rat pancreatic
carcinoma cells. Biochem Biophys Res Commun. 221:111–116. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bardosi S, Bardosi A, Nagy Z and Reglodi
D: Expression of PACAP and PAC1 receptor in normal human thyroid
gland and in thyroid papillary carcinoma. J Mol Neurosci.
60:171–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nakamura K, Nakamachi T, Endo K, Ito K,
Machida T, Oka T, Hori M, Ishizaka K and Shioda S: Distribution of
pituitary adenilate cyclase-activating polypeptide (PACAP) in the
human testis and in testicular germ cell tumours. Andrologia.
46:465–471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ndlovu R, Deng LC, Wu J, Li XK and Zhang
JS: Fibroblast growth factor 10 in pancreas development and
pancreatic cancer. Front Genet. 9:4822018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ishiwata T: Role of fibroblast growth
factor receptor-2 splicing in normal and cancer cells. Front Biosci
(Landmark Ed). 23:626–639. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu G, Xiong D, Xiao R and Huang Z:
Prognostic role of fibroblast growth factor receptor 2 in human
solid tumours: A systematic review and meta-analysis. Tumour Biol.
39:10104283177074242017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Saloman JL, Singhi AD, Hartman DJ,
Normolle DP, Albers KM and Davis BM: Systemic depletion of nerve
growth factor inhibits disease progression in a genetically
engineered model of pancreatic ductal adenocarcinoma. Pancreas.
47:856–863. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Melzer C, Hass R, von der Ohe J, Lehnert H
and Ungefroren H: The role of TGF-β and its crosstalk with
RAC1/RAC1b signaling in breast and pancreas carcinoma. Cell Commun
Signal. 15:192107. View Article : Google Scholar
|
|
44
|
Chiramel J, Backen AC, Pihlak R, Lamarca
A, Frizziero M, Tariq NU, Hubner RA, Valle JW, Amir E and McNamara
MG: Targeting the epidermal growth factor receptor in addition to
chemotherapy in patients with advanced pancreatic cancer: A
systematic review and meta-analysis. Int J Mol Sci. 18:E9092017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Weiss GA, Rossi MR, Khushalani NI, Lo K,
Gibbs JF, Bharthuar A, Cowell JK and Iyer R: Evaluation of
phosphatidylinositol-3-kinase catalytic subunit (PIK3CA) and
epidermal growth factor receptor (EGFR) gene mutations in
pancreaticobiliary adenocarcinoma. J Gastrointest Onco. 4:20–29.
2013.
|
|
46
|
Luo G, Long J, Qiu L, Liu C, Xu J and Yu
X: Role of epidermal growth factor receptor expression on patient
survival in pancreatic cancer: A meta-analysis. Pancreatology.
11:595–600. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gong Y, Zhang B, Liao Y, Tang Y, Mai C,
Chen T and Tang H: Serum insulin-like growth factor axis and the
risk of pancreatic cancer: Systematic review and meta-analysis.
Nutrients. 9:E3942017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Loosen SH, Neumann UP, Trautwein C,
Roderburg C and Luedde T: Current and future biomarkers for
pancreatic adenocarcinoma. Tumour Biol. 39:10104283176922312017.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yamaoka T, Ohba M and Ohmori T:
Molecular-targeted therapies for epidermal growth factor receptor
and its resistance mechanisms. Int J Mol Sci. 18:E24202017.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Le N, Sund M and Vinci A; GEMS
collaborating group of Pancreas 2000, : Prognostic and predictive
markers in pancreatic adenocarcinoma. Dig Liver Dis. 48:223–230.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fulop BD, Sandor B, Szentleleky E,
Karanyicz E, Reglodi D, Gaszner B, Zakany R, Hashimoto H, Juhasz T
and Tamas A: Altered notch signaling in developing molar teeth of
pituitary adenylate cyclase-activating polypeptide
(PACAP)-deficient mice. J Mol Neurosci. 68:377–388. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xu Z, Ohtaki H, Watanabe J, Miyamoto K,
Murai N, Sasaki S, Matsumoto M, Hashimoto H, Hiraizumi Y, Numazawa
S and Shioda S: Pituitary adenylate cyclase-activating polypeptide
(PACAP) contributes to the proliferation of hematopoietic
progenitor cells in murine bone marrow via PACAP-specific receptor.
Sci Rep. 6:223732016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sandor B, Fintor K, Reglodi D, Fulop DB,
Helyes Z, Szanto I, Nagy P, Hashimoto H and Tamas A: Structural and
morphometric comparison of lower incisors in PACAP-deficient and
wild-type mice. J Mol Neurosci. 59:300–308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zibara K, Zeidan A, Mallah K, Kassem N,
Awad A, Mazurier F, Badran B and El-Zein N: Signaling pathways
activated by PACAP in MCF-7 breast cancer cells. Cell Signal.
50:37–47. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Maugeri G, D'Amico AG, Reitano R, Magro G,
Cavallaro S, Salomone S and D'Agata V: PACAP and VIP inhibit the
invasiveness of glioblastoma cells exposed to hypoxia through the
regulation of HIFs and EGFR expression. Front Pharmacol. 7:1392016.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lee JH, Lee JY, Rho SB, Choi JS, Lee DG,
An S, Oh T, Choi DC and Lee SH: PACAP inhibits tumour growth and
interferes with clusterin in cervical carcinomas. FEBS Lett.
588:4730–4739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Juhász T, Matta C, Katona É, Somogyi C,
Takács R, Hajdú T, Helgadottir SL, Fodor J, Csernoch L, Tóth G, et
al: Pituitary adenylate cyclase-activating polypeptide (PACAP)
signalling enhances osteogenesis in UMR-106 cell line. J Mol
Neurosci. 54:555–573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Le SV, Yamaguchi DJ, McArdle CA, Tachiki
K, Pisegna JR and Germano P: PAC1 and PACAP expression, signaling,
and effect on the growth of HCT8, human colonic tumour cells. Regul
Pept. 109:115–125. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Farini D, Puglianiello A, Mammi C,
Siracusa G and Moretti C: Dual effect of pituitary adenylate
cyclase activating polypeptide on prostate tumour LNCaP cells:
Short- and long-term exposure affect proliferation and
neuroendocrine differentiation. Endocrinology. 144:1631–1643. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Reubi JC, Läderach U, Waser B, Gebbers JO,
Robberecht P and Laissue JA: Vasoactive intestinal
peptide/pituitary adenylate cyclase-activating peptide receptor
subtypes in human tumours and their tissues of origin. Cancer Res.
60:3105–3112. 2000.PubMed/NCBI
|
|
61
|
Hessenius C, Bäder M, Meinhold H, Böhmig
M, Faiss S, Reubi JC and Wiedenmann B: Vasoactive intestinal
peptide receptor scintigraphy in patients with pancreatic
adenocarcinomas or neuroendocrine tumours. Eur J Nucl Med.
27:1684–1693. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Raderer M, Kurtaran A, Yang Q, Meghdadi S,
Vorbeck F, Hejna M, Angelberger P, Kornek G, Pidlich J, Scheithauer
W and Virgolini I: Iodine-123-vasoactive intestinal peptide
receptor scanning in patients with pancreatic cancer. J Nucl Med.
39:1570–1575. 1998.PubMed/NCBI
|
|
63
|
Tang C, Biemond I, Offerhaus GJ, Verspaget
W and Lamers CB: Expression of receptors for gut peptides in human
pancreatic adenocarcinoma and tumour-free pancreas. Br J Cancer.
75:1467–1473. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Tamas A, Javorhazy A, Reglodi D, Sarlos
DP, Banyai D, Semjen D, Nemeth J, Lelesz B, Fulop DB and Szanto Z:
Examination of PACAP-like immunoreactivity in urogenital tumour
samples. J Mol Neurosci. 59:177–183. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Szanto Z, Sarszegi Z, Reglodi D, Nemeth J,
Szabadfi K, Kiss P, Varga A, Banki E, Csanaky K, Gaszner B, et al:
PACAP immunoreactivity in human malignant tumour samples and
cardiac diseases. J Mol Neurosci. 48:667–673. 2012. View Article : Google Scholar : PubMed/NCBI
|
